Description
Indication & Scope
WanHanLiangLi® Oseltamivir Phosphate Capsules is used for the treatment of influenza A and B in adults and children aged 1 year and above; also applicable for influenza prevention.
- Mechanism: Oseltamivir phosphate is a selective influenza virus neuraminidase inhibitor. It inhibits the activity of viral neuraminidase, blocks the release and spread of newly replicated influenza viruses in host cells, reduces virus proliferation, shortens influenza course and reduces infection risk.
- Drug class: Prescription systemic anti-influenza viral drug.
- Clinical use: Clinically used for early treatment of influenza A and B infection to relieve fever, soreness and respiratory symptoms; applied for post-exposure preventive medication of influenza virus.
| Generic Name | Oseltamivir Phosphate Capsules |
| Brand Name | WanHanLiangLi® |
| Ingredient | Oseltamivir Phosphate |
| Dosage Form | Capsules |
| Package | 75mg (Calculated by C₁₆H₂₈N₂O₄) *10 capsules/box;
75mg (Calculated by C₁₆H₂₈N₂O₄) *5 capsules/box; 75mg (Calculated by C₁₆H₂₈N₂O₄) *6 capsules/box; 75mg (Calculated by C₁₆H₂₈N₂O₄) *7 capsules/box; 75mg (Calculated by C₁₆H₂₈N₂O₄) *8 capsules/box; 75mg (Calculated by C₁₆H₂₈N₂O₄) *9 capsules/box |
| Conditions Treated | Influenza A infection, influenza B infection, influenza virus exposure prevention |
| Taboos | Hypersensitivity to oseltamivir phosphate or capsule excipients |
| Place of origin | China |
| Prescription type | Prescription‑only |
| Storage Conditions | Seal and store in a cool dry place, protected from light |
| Manufacturer | Zhongshan Wanhan Pahrmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20223437 |
| Approval Date | Jul 5, 2023 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: For treatment: 75 mg each time, twice a day for 5 consecutive days for adults. For prevention: 75 mg once a day for 7 to 10 consecutive days. Pediatric dosage adjusted by age and weight.
Time: Take within 48 hours after influenza symptom onset for optimal therapeutic effect; preventive medication taken regularly at fixed time daily.
Instructions for use: For oral use only. Strictly follow dosage and course of treatment. Early medication within 48 hours of symptom onset ensures best curative effect.
Interaction: No significant adverse drug interactions with common antipyretic and anti-inflammatory drugs. No obvious interaction with influenza vaccine.
Side effects: Mild and transient adverse reactions including occasional nausea, vomiting, abdominal pain and headache. Rare rash, fatigue and mild abnormal liver function, which recover after drug withdrawal.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What crowds are suitable for using Oseltamivir Phosphate Capsules?
Adults and children aged 1 year and above can use the capsules for influenza treatment and prevention.
What is the optimal medication time for influenza treatment when using Oseltamivir Phosphate Capsules?
Medication within 48 hours after the onset of influenza symptoms achieves the best therapeutic effect.
What are the main applicable scenarios of Oseltamivir Phosphate Capsules?
It is used for clinical treatment of influenza A and B and preventive medication after virus exposure.
What common mild adverse reactions may occur after taking Oseltamivir Phosphate Capsules?
Transient nausea, vomiting, abdominal pain and headache are common mild adverse reactions.
WanHanLiangLi® | Oseltamivir Phosphate Capsules | Influenza A and B | DengYueRX
INN: Oseltamivir Phosphate Capsules
Indications: Influenza A and B
Dosage Form: Capsules
Strength: 75mg (Calculated by C₁₆H₂₈N₂O₄) /capsule
Original price was: $3.15.$2.68Current price is: $2.68.
